🇺🇸 FDA
Pipeline program

Bioequivalence of Calcifediol monohydrate 0.266 mg Soft Capsules in Healthy Participants Under Fasting Conditions.

CFA-1037-1-24

Phase 1 other active

Quick answer

Bioequivalence of Calcifediol monohydrate 0.266 mg Soft Capsules in Healthy Participants Under Fasting Conditions. for No medical condition. is a Phase 1 program (other) at Laboratorios Tillomed Spain S.L.U with 1 ClinicalTrials.gov record(s).

Program details

Company
Laboratorios Tillomed Spain S.L.U
Indication
No medical condition.
Phase
Phase 1
Modality
other
Status
active

Clinical trials